Compare IDEXX Laboratories, Inc. (IDXX) vs State Street PDR S&P Retail ETF (XRT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs State Street PDR S&P Retail ETF — how do they compare? IDEXX Laboratories, Inc. trades at $572.04 (market cap $46.22B), while State Street PDR S&P Retail ETF trades at $88.91. The key difference: State Street PDR S&P Retail ETF is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| IDXX | XRT | |
|---|---|---|
Market Cap | $46.22B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $766.68 | $92.35 |
52-Week Low | $526.44 | $77.28 |
Enterprise Value | $47.12B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $571.44, down 4.08% over the past day, amid a mixed technical and strong fundamental backdrop. The stock shows a bullish trend in moving averages but overbought RSI readings near 73. Recent Q2 2026 earnings beat expectations with 9% organic revenue growth, and the company raised full-year EPS guidance. Profitability remains robust with a 25.03% net income margin and 74.21% ROE.
The outlook is positive given strong earnings momentum, high analyst buy ratings, and a consensus price target of $683.33 implying ~20% upside. Risks include premium valuation multiples and potential market volatility. The stock presents a growth opportunity supported by durable competitive advantages in veterinary diagnostics.
XRT (SPDR S&P Retail ETF) trades at $88.83, down 1.94% on the day, with technical indicators showing a bullish overall signal despite recent weakness. The ETF maintains neutral oscillators but strong directional movement indicators. Recent retail sales data shows five consecutive months of consumer spending growth, though sentiment remains challenged by inflation pressures and energy costs. The ETF provides diversified exposure to the retail sector with upcoming dividend distribution scheduled for June 2026.
The retail sector faces mixed signals with sustained consumer spending but macroeconomic headwinds. XRT's technical setup suggests potential near-term support around $88-89 levels, while fundamental exposure to discretionary retail remains sensitive to consumer confidence and inflation trends. Key risks include deteriorating consumer sentiment and competitive pressures within the retail landscape.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About State Street PDR S&P Retail ETF
XRT is an equal-weighted ETF that tracks the U.S. retail sector. It provides diversified exposure to apparel, automotive, and online retailers, including well-known names like Amazon, Target, and Costco.
Read more on XRT →
